4
Changes in Ownership
Nuvectis Pharma, Inc. Filed Acc 0001104659-22-014376
Chief Science & Business Off bought 4,600 shares at an average $3.44 ($15,834)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Poradosu Enrique Chief Science & Business Off | 2022-02-04 | Purchase | +3,800 | $3.35 | $12,730 | 1,196,849 | D |
| Poradosu Enrique Chief Science & Business Off | 2022-02-07 | Purchase | +800 | $3.88 | $3,104 | 1,197,649 | D |
| Open-market purchases · 4,600 sh · avg $3.44 · $15,834 | |||||||
Loading xslF345X03/tm225864-3_4seq1.xml…